ALEXION PHARMACEUTICALS, INC. Insider Trading for February 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for February 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Sell | S | 116.31 | 1,651 | 192,028 | 28,962 | 30.6 K to 29 K (-5.39 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 15,894 | 0 | 30,613 | 14.7 K to 30.6 K (+107.98 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Sell | S | 116.31 | 1,774 | 206,334 | 49,838 | 51.6 K to 49.8 K (-3.44 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Grant | A | 0.00 | 4,400 | 0 | 51,612 | 47.2 K to 51.6 K (+9.32 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Grant | A | 0.00 | 14,577 | 0 | 47,212 | 32.6 K to 47.2 K (+44.67 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Sell | S | 116.31 | 6,079 | 707,048 | 89,014 | 95.1 K to 89 K (-6.39 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Clancy Paul J | EVP, Chief Financia ... | Grant | A | 0.00 | 48,228 | 0 | 95,093 | 46.9 K to 95.1 K (+102.91 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Sell | S | 116.31 | 1,459 | 169,696 | 25,031 | 26.5 K to 25 K (-5.51 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Franchini Indrani Lall | EVP, Chief Complian ... | Grant | A | 0.00 | 13,908 | 0 | 26,490 | 12.6 K to 26.5 K (+110.54 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 116.31 | 4,787 | 556,776 | 44,412 | 49.2 K to 44.4 K (-9.73 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Grant | A | 0.00 | 7,500 | 0 | 49,199 | 41.7 K to 49.2 K (+17.99 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Grant | A | 0.00 | 21,489 | 0 | 41,699 | 20.2 K to 41.7 K (+106.33 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 115.70 | 1,200 | 138,840 | 74,537 | 75.7 K to 74.5 K (-1.58 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 115.70 | 2,163 | 250,259 | 75,737 | 77.9 K to 75.7 K (-2.78 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 6,500 | 0 | 77,900 | 71.4 K to 77.9 K (+9.10 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 21,489 | 0 | 71,400 | 49.9 K to 71.4 K (+43.05 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Sell | S | 116.31 | 13,245 | 1,540,526 | 118,180 | 131.4 K to 118.2 K (-10.08 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | HANTSON LUDWIG | CEO | Grant | A | 0.00 | 95,253 | 0 | 131,425 | 36.2 K to 131.4 K (+263.33 %) |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Reinsdorf Judith A | Director | Grant | A | 0.00 | 2,085 | 0 | 2,085 | 0 to 2.1 K |
Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,085 | 0 | 2,085 | 0 to 2.1 K |
Feb 07 2018 | ALXN | ALEXION PHARMACEUT ... | Wagner Heidi L | SVP, Global Governm ... | Sell | S | 117.26 | 655 | 76,805 | 32,635 | 33.3 K to 32.6 K (-1.97 %) |
Feb 07 2018 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 117.26 | 1,261 | 147,865 | 49,911 | 51.2 K to 49.9 K (-2.46 %) |
Feb 07 2018 | ALXN | ALEXION PHARMACEUT ... | O'Neill Julie | EVP. Global Operati ... | Sell | S | 117.26 | 2,119 | 248,474 | 20,210 | 22.3 K to 20.2 K (-9.49 %) |